Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate

被引:89
作者
Bonnotte, B
Favre, N
Reveneau, S
Micheau, O
Droin, N
Garrido, C
Fontana, A
Chauffert, B
Solary, E
Martin, F
机构
[1] Fac Med, Dept Biol & Therapy Canc, CJF INSERM 94 8, F-21033 Dijon, France
[2] Fac Med, EPHE, F-21033 Dijon, France
[3] Univ Zurich Hosp, Dept Internal Med, Zurich, Switzerland
关键词
apoptosis; colorectal cancer; Fas; sodium butyrate;
D O I
10.1038/sj.cdd.4400371
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer cells often resist Fas-mediated apoptosis even when the Fas receptor is expressed at the cell surf ace. We show here that human and rat colon cancer cells undergo massive apoptosis when they are exposed to soluble Fas ligand in the presence of sodium butyrate, an agent that induces by itself only a low rate of apoptosis, Sodium butyrate potentiates Fas-dependent apoptosis in seven out of eight colon cancer cell lines, Sodium butyrate does not increase Fas receptor cell surface expression and does not modify cell levels of Bcl-2, Bcl-x(L), Bcl-x(S) and Bar. Sodium butyrate also induces tumor cell sensitization to the apoptotic effect of the combination of TNF-alpha and IFN-gamma, but it does not modify the level of the FADD/Mort1 adaptator molecule, at the connection between Fas- and TNF-dependent apoptosis pathways. Because the clinical toxicity of butyrate is low, its ability to enhance Fas-signal delivery in cancer cells could be of therapeutic interest.
引用
收藏
页码:480 / 487
页数:8
相关论文
共 43 条
  • [1] ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147
  • [2] FAS-MEDIATED CYTOTOXICITY BY FRESHLY ISOLATED NATURAL-KILLER-CELLS
    ARASE, H
    ARASE, N
    SAITO, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) : 1235 - 1238
  • [3] AUGENLICHT LH, 1995, ADV EXP MED BIOL, V375, P137
  • [4] BARNARD JA, 1993, CELL GROWTH DIFFER, V4, P495
  • [5] INTERACTION BETWEEN 2 CELLULAR SUBPOPULATIONS OF A RAT COLONIC-CARCINOMA WHEN INOCULATED TO THE SYNGENEIC HOST
    CAIGNARD, A
    MARTIN, MS
    MICHEL, MF
    MARTIN, F
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (02) : 273 - 279
  • [6] PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE
    CHENG, JH
    ZHOU, T
    LIU, CD
    SHAPIRO, JP
    BRAUER, MJ
    KIEFER, MC
    BARR, PJ
    MOUNTZ, JD
    [J]. SCIENCE, 1994, 263 (5154) : 1759 - 1762
  • [7] SHORT CHAIN FATTY-ACIDS IN THE HUMAN-COLON
    CUMMINGS, JH
    [J]. GUT, 1981, 22 (09) : 763 - 779
  • [8] DEBATIN KM, 1995, LEUKEMIA, V9, P815
  • [9] Comparison of apoptosis in wild-type and fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions
    Eischen, CM
    Kottke, TJ
    Martins, LM
    Basi, GS
    Tung, JS
    Earnshaw, WC
    Leibson, PJ
    Kaufmann, SH
    [J]. BLOOD, 1997, 90 (03) : 935 - 943
  • [10] Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
    Friesen, C
    Herr, I
    Krammer, PH
    Debatin, KM
    [J]. NATURE MEDICINE, 1996, 2 (05) : 574 - 577